drug study for sale

8/12/2019 Drug Study for Sale

1/5

Generic

name

Brand

Name

Mechanism of

Action

Indications Contra-indications Adverse Effects Nursing Consideration

1.Celecoxib

Classification

:NSAID,

Analgesic(nonopioid),

Specific

COX-2enzyme

bloce!

Dosage:

2"" mgre!uenc":

#ID p!n fopain

#oute:

O!al

Celeb!ex Celecoxib $asCOX-2 specific

in$ibi%o!yac%i&i%y' I%

in$ibi%s %$econ&e!sion of

a!ac$idonic

acid %op!os%aglandins

$ile $a&ingno effec% on %$e

fo!ma%ion of

p!os%aglandins%$a% media%e

%$e no!mal$omeos%asis in

%$e I %!ac%,idneys and

pla%ele%s

ca%alyzed byCOX-*'

Ac+%e andlong-%e!m

%!ea%men% ofsigns and

symp%oms of!$e+ma%oid

a!%$!i%is and

os%eoa!%$!i%is

ed+c%ion of

%$e n+mbe! ofcolo!ec%al

polyps infamilial

adenoma%o+spolyposis

(A.)

/anagemen%

of ac+%e pain

0ype!sensi%i&i%yincl+ding %$ose in

$om a%%acs ofangioedema, !$ini%is

and +!%ica!ia $a&ebeen p!ecipi%a%ed by

aspi!in, NSAIDs o!

s+lfonamides'Se&e!e $epa%ic

impai!men%1 se&e!e$ea!% fail+!e1

inflamma%o!y boel

disease1 pep%ic +lce!1!enal impai!men%

(C!Cl 3" ml4min)1p!egnancy and

lac%a%ion'

Abdominal pain

Dia!!$ea

Na+sea

5dema Dizziness

0eadac$e

Insomnia

+ppe! !espi!a%o!y

%!ac% infec%ions

!as$

.o%en%ially a%al6

exfolia%i&e

de!ma%i%is

S%e&ens-7o$nson

synd!om

%oxic epide!mal

nec!olysis'

*' Info!m %$e pa%ien% %o %ae

d!+g i%$ food o! meals ifI +pse% occ+!s'

2' Info!m %$e pa%ien% %o %ae

only %$e p!esc!ibeddosage1 do no% inc!ease

dosage'

3' Info!m %$e pa%ien% %$a%

$e4s$e may expe!ience%$ese side effec%s6

Dizziness, d!osiness(a&oid d!i&ing o! %$e +se

of dange!o+s mac$ine!y$ile %aing %$is d!+g)'

8' Info!m %$e pa%ien% %o!epo!% so!e %$!oa%, fe&e!,

!as$, i%c$ing, eig$% gain,selling in anles o!

finge!s1 c$anges in &ision'


2/5

Generic

Name

Brand

Name

Mechanism of

Action

Indications Contraindications Adverse Effects Nursing Consideration

$.Cef+!oximeAxe%il

Classification:

Anti-infective

Dosage: 9:"

mgre!uenc":

; ANS?

Cef+!oximeAxe%il

(Cef%in@.'O')

Second-gene!a%ion

cep$alospo!in%$a% in$ibi%s

cell-allsyn%$esis,

p!omo%ing

osmo%icins%abili%y1

+s+allybac%e!icidal'

.$a!yngi%is,%onsilli%is,

infec%ions of %$e+!ina!y and loe!

!espi!a%o!y %!ac%s,and sin and sin-

s%!+c%+!e

infec%ionsBncomplica%ed

B?Is

O%i%is /edia

.$a!yngi%is and

?onsilli%is

5a!ly ymeDisease

Seconda!ybac%e!ial infec%ion

of ac+%e b!onc$i%is

Bncomplica%ed

gono!!$ea'

Con%!aindica%ed inpa%ien%s

$ype!sensi%i&e %od!+g'

Bse ca+%io+sly in

pa%ien%s

$ype!sensi%i&e %openicillin beca+se of

possibili%y of c!oss-sensi%i&i%y i%$ o%$e!

be%a-lac%am

an%ibio%ics'

Bse i%$ ca+%ion inb!eas%-feeding

omen and inpa%ien%s i%$ $is%o!y

of coli%is o! !enal

s+fficiency'

C>6 p$lebi%is,%$!ombop$lebi%is

I6

pse+domemb!ano+scoli%is, na+sea,

ano!exia, &omi%ing,

dia!!$ea

0ema%ologic6%!ansien%

ne+%!openia,

eosinop$ilia,$emoly%ic anemia,

?$!ombocy%openia

Sin6mac+lopap+la! and

e!y%$ema%o+s

!as$es, +!%ica!ia,pain, ind+!a%ion,

s%e!ile abscesses,%empe!a%+!e

ele&a%ion'

O%$e!6

$ype!sensi%i&i%y!eac%ions, se!+m

sicness,anap$ylaxis'

2' #efo!e adminis%e!ing,mae s+!e pa%ien% is no%

alle!gic %o penicillins o!cep$alospo!ins'

3' Abso!p%ion of cef+!oxime

axe%il is en$anced by food'

8' Cef+!oxime axe%il %able%s

may be c!+s$ed if salloingis a diffic+l%y'

:' ?ae medica%ion asp!esc!ibed, e&en af%e! feeling

be%%e!'

E' ?ae o!al fo!m i%$ food'

9' If s+spension is being +sed,

s$ae %$e con%aine! ellbefo!e meas+!ing dose'


3/5

Generic

Name

Brand

Name

Mechanism of

Action

Indication Contraindications Adverse

Effects

Nursing Consideration

%..AAC5

?A/O

Classificati

on: An%i-

py!e%ic4Analgesic

orm:

?able%s

Dosage:

:"" mg

re!uenc":F 8 4 .N

#oute:

O!al

#iogesic ?$o+g$% %o

p!od+ceanalgesia by

blocing painimp+lses by

in$ibi%ing

syn%$esis ofp!os%aglandin

in %$e CNS o!of o%$e!

s+bs%ances %$a%

sensi%ize pain!ecep%o!s %o

s%im+la%ion'?$e d!+g may

!elie&e fe&e!%$!o+g$ cen%!al

ac%ion in %$e

$ypo%$alamic$ea%-!eg+la%ing

cen%e!'

G/ild pain

o! e&e!

GCon%!aindica%ed in

pa%ien% $ype!sensi%i&e %od!+g'

GBse ca+%io+sly inpa%ien% i%$ long %e!m

alco$ol +se beca+se

%$e!ape+%ic doses ca+se$apa%o%oxici%y in %$is

pa%ien%s'

G0ema%ologic6

$emoly%icanemia,

ne+%!openia,le+copenia,

pancy%openia'

G0epa%ic6Ha+ndice

G/e%abolic6$ypoglycemia

GSin6 !as$,

+!%ica!ia'

*' Ad&ise pa%ien% %$a% d!+g is only

fo! s$o!% %e!m +se and %o cons+l%p!esc!ibe! if gi&ing %o c$ild!en fo!

longe! %$an fi&e days o! ad+l% fo!longe! %$an %en days'

2' ?ell pa%ien% no% %o +se fo! ma!edfe&e!( %empe!a%+!e $ig$e! %$an *"3'*

@3': C), fe&e! pe!sis%ing longe!%$an %$!ee days, o! !ec+!!en% fe&e!

+nless di!ec%ed by p!esc!ibe!'

3' Ale!%6 Ja!n pa%ien% %$a% $ig$

doses o! +ns+pe!&ised long %e!m +secan ca+se li&e! damage'

8' ?ell %o b!eas% feeding oman %$a%

ace%aminop$en appea!s in b!eas%

mil lo le&els ( less %$an *K dose)'D!+g may be +sed safely if %$e!apy

is s$o!% %e!m and doesnL% exceed!ecommended doses'


4/5

Generic

Name

Brand

Name

Mechanism of

Action

Indication Contraindications Adverse Effects Nursing Consideration

&. 5!dos%ein

Classificati

on:m+coly%ic

agen%

orm:

Caps+le

Dosage:

3"" mg

re!uenc":

#ID

#oute:O!al

Me!%in Ac%s as a p!od!+g

and i%s me%aboli%esa!e mainly

!esponsible fo!m+coly%ic ac%i&i%y'

I% o!s by $elping%o b!ea don

m+c+s sec!e%ions'

?!ea%men% of

ac+%e andc$!onic

b!onc$op+lmona!y

disease

Con%!aindica%ed in

pa%ien%s i%$ pep%ic+lce!, .!egnancy and

$ype!sensi%i&i%y'

S%omac$ pain

Na+sea

>omi%ing

loose s%ools spasmodic

coli%is

$eadac$e'

*' #efo!e gi&ing %$e medica%ionmae s+!e %$a% %$e clien% is no%

p!egnan% and non lac%a%ing'

2' Info!m %$e pa%ien% %$a% i% canbe %aen i%$ o! i%$o+% food'

3' As %$e pa%ien% %o no%ify anyof %$e $eal%$ca!e %eam if %$e $e

feels na+sea, &omi%ing,abdominal pain o! %a!!y s%ools

occ+!'

8' 5mp$asize %$e impo!%ance

follo +p exams


5/5

Generic

Name

Brand

Name

Mechanism of

Action

Indication Contraindications Adverse Effects Nursing Consideration

'..!ednisone

Classificatio

n:Co!%icos%e!oid(in%e!media%eac%ing),l+coco!%icoid, 0o!mone

orm:?able%

Dosage:

: mgre!uenc":

?ID

#oute:

O!al

Del%asone I% dec!easesinflamma%ion bys+pp!ession ofmig!a%ion of

polymo!p$on+clea! le+ocy%es and

!e&e!sal ofinc!eased capilla!y

pe!meabili%y1s+pp!esses %$e

imm+ne sys%em by!ed+cing ac%i&i%y

and &ol of %$elymp$a%ic sys%em1s+pp!esses ad!enal

f+nc%ion a% $ig$doses' Indica%ionsand dosage a!esame as %$ose fo!

p!ednisolone'

S$o!%-%e!m

managemen% of

&a!io+s

inflamma%o!y and

alle!gic diso!de!s,s+c$ as

!$e+ma%oid

a!%$!i%is, collagen

diseases (eg,

S5),

de!ma%ologic

diseases (eg,

pemp$ig+s), s%a%+s

as%$ma%ic+s, and

a+%oimm+nediso!de!s'

eplacemen%

%$e!apy in ad!enal

co!%ical

ins+fficiency

0ype!sensi%i&i%y,

se!io+s infec%ions

(excep% %+be!c+lo+s

meningi%is), &a!icella,

sys%emic f+ngalinfec%ions'

Insomnia,ne!&o+sness,inc!eased appe%i%e,indiges%ion,

dizziness4lig$%$eadedness, $eadac$e,

$i!s+%ism,$ypopigmen%a%ion,

diabe%es melli%+s,gl+cose in%ole!ance,

$ype!glycaemia,a!%$!algia, ca%a!ac%s,

gla+coma, epis%axis,diap$o!esis,C+s$ings synd!ome,

edema, f!ac%+!es,$all+cina%ions,$ype!%ension, m+scle-as%ing,os%eopo!osis,

panc!ea%i%is, pi%+i%a!y-ad!enal axiss+pp!ession, seiz+!es'

*' Info!m %$e p%' %o do no% s%op%aing %$e d!+g i%$o+%

cons+l%ing yo+! $eal%$ ca!ep!o&ide!1

2' Info!m %$e p%' %o A&oid

expos+!e %o infec%ions'

3' Info!m %$e p%' %o epo!%

+n+s+al eig$% gain, sellingof %$e ex%!emi%ies, m+scle

eaness, blac o! %a!!y s%ools,

fe&e!, p!olonged so!e %$!oa%,colds o! o%$e! infec%ions,

o!sening of %$e diso!de! fo!$ic$ %$e d!+g is being %aen'

drug study for sale

Documents